Study on MicroRNAs as Biomarkers for Suicidality in Adolescents
A clinical trial is underway to identify biomarkers for depression and suicidality in adolescents, focusing on neural-derived plasma exosomal microRNAs.
Phase III
Psychiatry / Depression
Status
Active
Signal Score
8.2
Signal assessment
Signal strength
high
Confidence level
moderate
Why it matters
This study is significant as it explores novel biomarkers that could revolutionize the diagnosis and treatment of depression and suicidality in adolescents. The outcomes may lead to enhanced treatment protocols, impacting competitive positioning in the mental health sector.
Recommended action
Humanexa recommends Monitor.
Analysis
Monitor results of the trial for insights on biomarkers and treatment outcomes, as well as any subsequent publications or follow-up studies.
Related companies & assets
Sources & Humanexa intelligence
Related Humanexa pages
Related signals
Newsletter
Get signals before the market moves
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.